Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:06 pm Purchase | 2021-12-31 | 13G | INTELLIA THERAPEUTICS INC NTLA | REGENERON PHARMACEUTICALS INC. REGN | 3,702,995 4.980% | 925,218 (+33.31%) | Filing History |
| 2022-02-11 4:05 pm Purchase | 2021-12-31 | 13G | DECIBEL THERAPEUTICS INC DBTX | REGENERON PHARMACEUTICALS INC. REGN | 2,097,314 8.420% | 2,097,314 (New Position) | Filing History |
| 2022-02-11 2:48 pm Sale | 2022-02-14 | 13G | REGENERON PHARMACEUTICALS INC REGN | Capital World Investors | 5,391,870 5.100% | -1,625,252 (-23.16%) | Filing History |
| 2022-02-10 08:32 am Purchase | 2021-12-31 | 13G | REGENERON PHARMACEUTICALS INC REGN | VANGUARD GROUP INC | 8,158,515 7.720% | 227,295 (+2.87%) | Filing History |
| 2022-02-09 10:24 am Sale | 2022-02-08 | 13G | REGENERON PHARMACEUTICALS INC REGN | FMR LLC | 10,062,965 9.518% | -1,418,606 (-12.36%) | Filing History |
| 2022-02-01 5:08 pm Sale | 2021-12-31 | 13G | REGENERON PHARMACEUTICALS INC REGN | BlackRock Inc. BLK | 9,610,871 9.100% | -165,315 (-1.69%) | Filing History |